Prosecution Insights
Last updated: July 17, 2026
Application No. 17/994,874

PENILE SLEEVE DEVICES AND METHODS OF MAKING THE SAME

Non-Final OA §103§112
Filed
Nov 28, 2022
Priority
May 20, 2019 — divisional of 10/517,730 +2 more
Examiner
HONRATH, MARC D
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Loria Products LLC
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allowance Rate
100 granted / 134 resolved
+4.6% vs TC avg
Strong +30% interview lift
Without
With
+30.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
31 currently pending
Career history
171
Total Applications
across all art units

Statute-Specific Performance

§101
2.6%
-37.4% vs TC avg
§103
61.7%
+21.7% vs TC avg
§102
3.8%
-36.2% vs TC avg
§112
22.2%
-17.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 134 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of invention I and species I, claims 1-12, in the reply filed on 13 March 2026 is acknowledged. The previous office action included claim 13 in both invention I and invention II, but the method of invention II starts with claim 13, with the penile sleeve device limited to claims 1-12 and 16-23, therefore the invention I and species I is limited to claims 1-12. Claims 1-23 are pending in the instant application, but claims 13-23 are withdrawn from consideration. Specification The lengthy specification has not been checked to the extent necessary to determine the presence of all possible minor errors. Applicant’s cooperation is requested in correcting any errors of which applicant may become aware in the specification. Claim Objections Claims 2 and 3 are objected to because of the following informalities: Claim 2, line 1 states “wherein each V-cuts” but should read --wherein each V-cut of the plurality of V-cuts-- for grammar and antecedent basis. Claim 3, line 2 states “a second plurality plurality of V-cuts” but should read -- a second plurality of V-cuts--. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-12 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1, line 8, recites the limitation "a shorter arcuate shaped configuration " which renders the claim indefinite because it is not clear what the arcuate shaped configuration is being compared to. Claim 1, line 16, recites the limitation " the silicone material" but line 7 recites “a bio-implantable reinforced silicon rubber” which renders the claim indefinite because it is not clear if the silicone material is referencing the silicon rubber of line 7. Claims 2-12 inherit the same deficiencies. Claim 12, line 1, recites the limitation “said indicia”, There is insufficient antecedent basis for this limitation in the claim. Claim 12 is dependent on claim 9 but should be dependent on claim 11. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1, 2, and 5-9 are rejected under 35 U.S.C. 103 as being unpatentable over Cornell (US20200022812A1) and further in view of Loria (US9877835B1). Regarding claim 1, Cornell discloses a penile sleeve device configured for implantation in the subcutaneous space of a patient's penis for enhancing or correcting penis shape and size (Abstract), the penis having a glans, a penile shaft and a proximal end at a pubic area of the patient (Figure 14B), said penile sleeve device comprising an elongated member having a longitudinal axis (Figure 1) and formed of a bio-implantable reinforced silicon rubber (Paragraph [0032]), said elongated member having a distal portion comprising a C-shaped configuration (Figure 1 and Figure 4) and having a proximal portion having a shorter arcuate shaped configuration (Figure 1 and Figure 3, the interior circumference of the proximal portion is smaller than the interior circumference of the distal portion (Figure 4)) and wherein said elongated member further comprises a transitional portion formed between said distal portion and said proximal portion (Figure 2, this could be interpreted as the straight portion of the device), said distal portion configured for implantation on the patient's penile shaft adjacent the glans of the patient's penis and said proximal portion configured for implantation on the patient's penile shaft adjacent the pubic area of the patient (Paragraph [0048]), said elongated member having a pair of longitudinal edges from said distal portion, through said transitional portion and through said proximal portion (Figure 2). Cornell does not disclose said longitudinal edges each comprise a plurality of V-cuts transversely oriented with regard to said longitudinal axis (the limitation “to avoid or minimize any buckling of the silicone material in said penile sleeve device if the penis is ever rotated or twisted with said penile sleeve device implanted therein.” Is written as intended use). Loria discloses a penile insert device effective to prevent retraction of the penis and to increase the length of a penis in its flaccid or erect state. Loria further discloses the insert device comprises a plurality of alternating lateral plateaus and lateral valleys (Abstract) which serve to provide for a bendable device that can move with the movement of the penis without causing discomfort to the user (Col 2, lines 14-15). It would have been obvious before the effective filing date of the claimed invention to one having ordinary skill in the art to modify the device as taught by Cornel, with the longitudinal edges each comprising a plurality of V-cuts transversely oriented with regard to said longitudinal axis as taught by Loria, since such a modification would provide the predictable results of a bendable device that can move with the movement of the penis without causing discomfort to the user (Loria, Col 2, lines 14-15). Regarding claim 2, Cornell, as modified by Loria, discloses each V-cut is oriented such that a wider opening of said V-cut is along a longitudinal edge, with said V -cut tapering down in a direction towards a dorsal region of said penile sleeve device (Loria, Figure 1). Regarding claim 5, Cornell, as modified by Loria, discloses said elongated member comprises a durometer of Shore A (40-50) (Cornell, Paragraph [0034]). Regrading claims 6-8, Cornell, as modified by Loria, discloses the elongate edges to include distal and proximal portions have pillowed or rounded edges (Cornell, Paragraph [0048]). Regarding claim 9, Cornell, as modified by Loria, discloses thickness of said elongated member in a portion of said distal portion increases towards a thickness of said elongated member in said transitional portion (Paragraph [0048]). Allowable Subject Matter Claims 3, 4, an 10-12 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: Regarding claims 3 and 4, Loria is the closest prior art for teaching the use of V-cuts in a penile implant, but Loria does not disclose the V-cuts may vary in size, wherein the V-cuts vary in size along the longitudinal axis of the elongate member. Regarding claim 10, Cornell is the closest prior art for teaching a penile implant with a vary thickness along the longitudinal axis, but Cornell does not teach a thickness of said elongated member in a portion of said proximal portion decreases towards a proximal end of said elongated member. Regarding claims 11 and 12, the prior art does not teach a penile implant that comprises the limitations of claim 1, wherein indicia is provided at a distal end on a dorsal side of said elongated member, and wherein the indicia is a notch. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Marc D Honrath whose telephone number is (571)272-6219. The examiner can normally be reached M-F 7:30-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Charles A Marmor II can be reached at (571) 272-4730. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CHARLES A MARMOR II/Supervisory Patent Examiner Art Unit 3791 /M.D.H./Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Nov 28, 2022
Application Filed
May 27, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12668164
SYSTEM FOR MINIMIZING RISK OF TRANSMISSION OF INFECTION
5y 11m to grant Granted Jun 30, 2026
Patent 12667454
URINARY INCONTINENCE AUTOMATIC CONTROL SYSTEM HAVING MULTI-POINT ALTERNATE SWITCHING FUNCTION, AND IN-VIVO MACHINE THEREOF
4y 1m to grant Granted Jun 30, 2026
Patent 12654036
METHOD FOR TREATING HEART FAILURE BY IMPROVING EJECTION FRACTION OF A PATIENT
6y 9m to grant Granted Jun 16, 2026
Patent 12653675
DEVICE FOR EXTENDING A LENGTH OF A PENILE IMPLANT
4y 4m to grant Granted Jun 16, 2026
Patent 12636487
Systems and Methods for Musculoskeletal Tissue Treatment
4y 3m to grant Granted May 26, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
99%
With Interview (+30.2%)
3y 2m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 134 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month